Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Annovis Bio, Inc.

NYSE: ANVS · Life Sciences · 7 alerts · CIK 1477845

Share price
$0.7500Close, Nov 16
Market cap
$46.5M
Shares outstanding
62.02MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Annovis Bio, Inc. filings on SEC EDGAR ↗

5:25 PM ET 8-K
Capital Raise

Annovis Bio Capital Raise of $21M

Annovis Bio entered into an underwriting agreement to raise approximately $21.0 million through a public offering of 19,000,000 shares of common stock and 2,000,000 pre-funded warrants, accompanied by warrants to purchase an additional 21,000,000 shares. The company intends to use the proceeds for the clinical development of its lead compound, Buntanetap, in studies for Alzheimer’s and Parkinson’s disease.

Value
$21M
Counterparty
Canaccord Genuity LLC
5:11 PM ET 8-K
Nasdaq/NYSE Compliance Notice

Annovis Bio Nasdaq/NYSE Compliance Notice

Annovis Bio received a deficiency notice from the NYSE for failing to maintain a minimum average market capitalization of $50 million and stockholders' equity of $50 million over a 30-day period. The company has 45 days to submit a compliance plan and 9 months to regain compliance to avoid delisting. During this period, the stock will continue to trade under the symbol 'ANVS' with an added '.BC' designation.

Counterparty
NYSE
Term
9 months

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.